CD29 (integrin β1) forms heterodimers with various α subunits (CD49a to CD49f), known as Very Late Antigens (VLA), which is involved in cell adhesion, tumor growth, invasion, angiogenesis, immune response, and therapeutic resistance. The gene discussed is ITGB1; the disease is neoplasm.